RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER, PHASE II STUDY OF ECULIZUMAB IN PATIENTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)

被引：0

作者：

Howard, J. F. ^{[1
]}

Barohn, R. ^{[2
]}

Cutter, G. ^{[3
]}

Freimer, M. ^{[4
]}

Juel, V. ^{[5
]}

Mozaffar, T. ^{[6
]}

Mellion, M. ^{[7
]}

Benatar, M. ^{[8
]}

Farragia, M. ^{[9
]}

Pulley, M. ^{[10
,11
]}

Gorson, K. ^{[12
]}

Chaudry, V. ^{[13
]}

Pascuzzi, R. ^{[14
]}

Siddiqi, Z. ^{[15
]}

Kissell, J. T. ^{[15
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC USA

[2] Univ Kansas, Lawrence, KS 66045 USA

[3] Univ Alabama, Sch Publ Hlth, Birmingham, AL 35294 USA

[4] Ohio State Univ, Columbus, OH 43210 USA

[5] Duke Univ, Durham, NC USA

[6] Univ Calif Irvine, Irvine, CA USA

[7] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA

[8] Univ Miami, Miami, FL USA

[9] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland

[10] Univ Florida, Jacksonville, FL USA

[11] Shands Neurosci Inst, Jacksonville, FL USA

[12] Caritas St Elizabeths Med Ctr, Brighton, MA USA

[13] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[14] Wishard Mem Hosp, Indianapolis, IN USA

[15] Univ Alberta Hosp, Edmonton, AB, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：689 / 690

页数：2